OptimizeRx Corporation Common Stock
OPRXOptimizeRx Corporation (OPRX) is a digital health company that provides a platform connecting healthcare providers and pharmaceutical companies. It delivers real-time, point-of-care communication solutions aimed at improving patient outcomes by streamlining the delivery of medication information, reimbursement support, and adherence programs within the healthcare ecosystem.
Company News
OptimizeRx announced the launch of its patent-pending Natural Language Audience Builder (NLAB), an AI-powered tool designed to be embedded in demand-side platforms and agency media planning platforms. The technology enables life sciences companies and marketers to build custom HCP audiences using natural-language prompts, combining real-world evi...
OptimizeRx Corp. announced four new partner agreements expanding its point-of-care network, increasing National Provider Identifier (NPI) reach by 37% through exclusive partnerships with e-prescribing platforms and health systems access partners.
OptimizeRx Corp. has received a purported notice of nominations from a stockholder, Whetstone Capital Advisors, LLC, regarding its intention to nominate two candidates for election to the OptimizeRx Board of Directors at the Company's 2025 Annual Meeting of Stockholders.
Smith Micro Software, Inc. reported a Q2 loss of $0.38 per share, missing the Zacks Consensus Estimate of a loss of $0.35. The company's revenue of $5.14 million also missed estimates. The stock has lost about 62.9% since the beginning of the year.
• 84% of Patients Arrive at Doctor Visits Underinformed• Underscores Growing Importance of HCP and DTC Alignment in Pharma Commercialization and Marketing Strategies• OPRX Closes First Combined HCP and DTC DAAP Marketing Program for Top 5 Pharma Client
